Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain

NCT01967524 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01967524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01967524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2013
Completion date
August 31, 2016
Enrollment
80 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pelviperineal pain